Clinical Trial Update: Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial [Phase 2]

View source ↗

Summary

Phase II randomized study evaluating panitumumab with trifluridine-tipiracil in pretreated RAS wild-type metastatic colorectal cancer (VELO Trial) has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Panitumumab (Vectibix) (panitumumab)
• trifluridine-tipiracil (Lonsurf) (trifluridine-tipiracil)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Metastatic Colon Cancer | Phase 2 | Status: COMPLETED